Brief Behavioral Treatment for Sleep Problems in IBS Study
| Status: | Recruiting |
|---|---|
| Conditions: | Insomnia Sleep Studies, Irritable Bowel Syndrome (IBS) |
| Therapuetic Areas: | Gastroenterology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 20 - 50 |
| Updated: | 3/1/2019 |
| Start Date: | March 3, 2017 |
| End Date: | September 2019 |
| Contact: | Sarah Ballou, Ph.D |
| Email: | sballou@bidmc.harvard.edu |
| Phone: | 617-667-0689 |
Brief Behavioral Treatment for Sleep Problems in Irritable Bowel Syndrome: a Pilot Study
Patients with Irritable Bowel Syndrome (IBS) often report more fatigue and sleep disturbances
compared to their healthy counterparts and compared to patients with other GI disorders. This
pilot study will evaluate the feasibility of a Brief Behavioral Treatment for Insomnia
(BBT-I) in Irritable Bowel Syndrome. 40 participants will be recruited; 20 will receive 4
weeks of BBT and 20 will be assigned to a wait list control group (WLC). The primary aim of
the current project is to assess feasibility of administering BBT-I to a sample of patients
with IBS. Because behavioral sleep treatment has not yet been studied in IBS or any other GI
population, this project will provide information about treatment adherence, recruitment, and
effect sizes. Secondary aims include evaluating the impact of BBT-I on sleep quality and IBS
symptom severity.
compared to their healthy counterparts and compared to patients with other GI disorders. This
pilot study will evaluate the feasibility of a Brief Behavioral Treatment for Insomnia
(BBT-I) in Irritable Bowel Syndrome. 40 participants will be recruited; 20 will receive 4
weeks of BBT and 20 will be assigned to a wait list control group (WLC). The primary aim of
the current project is to assess feasibility of administering BBT-I to a sample of patients
with IBS. Because behavioral sleep treatment has not yet been studied in IBS or any other GI
population, this project will provide information about treatment adherence, recruitment, and
effect sizes. Secondary aims include evaluating the impact of BBT-I on sleep quality and IBS
symptom severity.
Inclusion Criteria:
- Age 20-50
- Meet diagnostic criteria for IBS
- Stable medication for IBS for at least 1 month
- Stable medication for sleep for at least 1 month
- ISI cutoff score of 10 or higher
- Completes at least 5 out of 7 days of daily symptom and sleep diary during 1 week
baseline
Exclusion Criteria:
- Medical history of significant head injury or other neurological disorder
- Pregnancy (self-reported)
- Post-menopause
- Major concomitant medical conditions
- Major psychiatric diagnosis with comorbid sleep problems
- Taking medications that might interfere with sleep
- Confirmed or suspected other untreated sleep disorder
- Active illicit drug use
We found this trial at
1
site
330 Brookline Ave
Boston, Massachusetts 02215
Boston, Massachusetts 02215
617-667-7000
Phone: 617-667-0689
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
Click here to add this to my saved trials
